Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

Similar articles for PubMed (Select 22520214)

1.

Treatment of adult MPSI mouse brains with IDUA-expressing mesenchymal stem cells decreases GAG deposition and improves exploratory behavior.

da Silva FH, Pereira VG, Yasumura EG, Tenório LZ, de Carvalho LP, Lisboa BC, Matsumoto PK, Stilhano RS, Samoto VY, Calegare BF, Brandão Lde C, D'Almeida V, Filippo TR, Porcionatto M, Toma L, Nader HB, Valero VB, Camassola M, Nardi NB, Han SW.

Genet Vaccines Ther. 2012 Apr 20;10(1):2. doi: 10.1186/1479-0556-10-2.

2.

Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I.

Pasqualim G, Baldo G, de Carvalho TG, Tavares AM, Giugliani R, Matte U.

PLoS One. 2015 Feb 3;10(2):e0117271. doi: 10.1371/journal.pone.0117271. eCollection 2015.

3.

α- L-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice.

Stilhano RS, Martin PK, de Melo SM, Samoto VY, Peres GB, da Silva Michelacci YM, da Silva FH, Pereira VG, D'Almeida V, da Cruz AT, Jasiulionis MG, Han SW.

J Gene Med. 2015 Jan-Feb;17(1-2):1-13. doi: 10.1002/jgm.2818.

PMID:
25597593
4.

Lessons from molecular modeling human α-L-iduronidase.

Figueiredo DF, Antunes DA, Rigo MM, Mendes MF, Silva JP, Mayer FQ, Matte U, Giugliani R, Vieira GF, Sinigaglia M.

J Mol Graph Model. 2014 Nov;54:107-13. doi: 10.1016/j.jmgm.2014.10.004. Epub 2014 Oct 18.

PMID:
25459762
5.

Analysis of male reproductive parameters in a murine model of mucopolysaccharidosis type I (MPS I).

do Nascimento CC, Junior OA, D'Almeida V.

Int J Clin Exp Pathol. 2014 May 15;7(6):3488-97. eCollection 2014.

6.

Mesenchymal stem cells do not prevent antibody responses against human α-L-iduronidase when used to treat mucopolysaccharidosis type I.

Martin PK, Stilhano RS, Samoto VY, Takiya CM, Peres GB, da Silva Michelacci YM, da Silva FH, Pereira VG, D'Almeida V, Marques FL, Otake AH, Chammas R, Han SW.

PLoS One. 2014 Mar 18;9(3):e92420. doi: 10.1371/journal.pone.0092420. eCollection 2014.

7.

Retroviral-vector-mediated gene therapy to mucopolysaccharidosis I mice improves sensorimotor impairments and other behavioral deficits.

Baldo G, Wozniak DF, Ohlemiller KK, Zhang Y, Giugliani R, Ponder KP.

J Inherit Metab Dis. 2013 May;36(3):499-512. doi: 10.1007/s10545-012-9530-x. Epub 2012 Sep 15.

8.

Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice.

Baldo G, Mayer FQ, Martinelli B, Meyer FS, Burin M, Meurer L, Tavares AM, Giugliani R, Matte U.

Cytotherapy. 2012 Aug;14(7):860-7. doi: 10.3109/14653249.2012.672730. Epub 2012 Apr 3.

PMID:
22472038
9.

Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I.

Wolf DA, Lenander AW, Nan Z, Braunlin EA, Podetz-Pedersen KM, Whitley CB, Gupta P, Low WC, McIvor RS.

Bone Marrow Transplant. 2012 Sep;47(9):1235-40. doi: 10.1038/bmt.2011.239. Epub 2011 Dec 19.

10.

Genomic instability in blood cells from murine model of mucopolysaccharidosis type I.

Noguti J, Pereira VG, Martins AM, D'Almeida V, Ribeiro DA.

J Mol Histol. 2011 Dec;42(6):575-8. doi: 10.1007/s10735-011-9361-3. Epub 2011 Oct 1.

PMID:
21965007
11.

Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder.

Lau AA, Rozaklis T, Ibanes S, Luck AJ, Beard H, Hassiotis S, Mazouni K, Hopwood JJ, Kremer EJ, Hemsley KM.

Gene. 2012 Jan 1;491(1):53-7. doi: 10.1016/j.gene.2011.09.004. Epub 2011 Sep 22.

PMID:
21963444
12.

Evaluation of α-iduronidase in dried blood spots is an accurate tool for mucopolysaccharidosis I diagnosis.

Müller KB, Pereira VG, Martins AM, D'Almeida V.

J Clin Lab Anal. 2011;25(4):251-4. doi: 10.1002/jcla.20468.

PMID:
21786328
13.

Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.

Baldo G, Quoos Mayer F, Burin M, Carrillo-Farga J, Matte U, Giugliani R.

Cells Tissues Organs. 2012;195(4):323-9. doi: 10.1159/000327532. Epub 2011 Jul 19.

PMID:
21778683
14.

Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model.

Piller Puicher E, Tomanin R, Salvalaio M, Friso A, Hortelano G, Marin O, Scarpa M.

Gene Ther. 2012 Apr;19(4):355-64. doi: 10.1038/gt.2011.94. Epub 2011 Jun 30.

PMID:
21716300
15.

Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.

Boado RJ, Hui EK, Lu JZ, Zhou QH, Pardridge WM.

Mol Pharm. 2011 Aug 1;8(4):1342-50. doi: 10.1021/mp200136x. Epub 2011 Jun 17.

PMID:
21667973
16.

[Mutation analysis and prenatal diagnosis of 2 cases with mucopolysaccharidosis type I].

Wang XN, Wei M, Shi HP, Qiu ZQ, Yao FX, Meng Y, Zhang WM.

Zhonghua Er Ke Za Zhi. 2011 Apr;49(4):306-10. Chinese.

PMID:
21624210
17.

Lipid composition of whole brain and cerebellum in Hurler syndrome (MPS IH) mice.

Heinecke KA, Peacock BN, Blazar BR, Tolar J, Seyfried TN.

Neurochem Res. 2011 Sep;36(9):1669-76. doi: 10.1007/s11064-011-0400-y. Epub 2011 Jan 21.

PMID:
21253856
18.

Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.

Aldenhoven M, de Koning TJ, Verheijen FW, Prinsen BH, Wijburg FA, van der Ploeg AT, de Sain-van der Velden MG, Boelens J.

Biol Blood Marrow Transplant. 2010 May;16(5):701-4. doi: 10.1016/j.bbmt.2010.01.006. Epub 2010 Jan 21.

19.

Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis.

Pereira VG, Gazarini ML, Rodrigues LC, da Silva FH, Han SW, Martins AM, Tersariol IL, D'Almeida V.

J Cell Physiol. 2010 May;223(2):335-42. doi: 10.1002/jcp.22039.

PMID:
20082302
20.

Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.

Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K.

J Gene Med. 2009 May;11(5):373-81. doi: 10.1002/jgm.1313.

PMID:
19274675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk